BlackRock’s Regencell Bioscience RGC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $146K | Sell |
8,589
-5,205
| -38% | -$88.7K | ﹤0.01% | 4674 |
|
|
2025
Q1 | $11.6K | Buy |
13,794
+4,750
| +53% | +$3.99K | ﹤0.01% | 5117 |
|
|
2024
Q4 | $1.18K | Hold |
9,044
| – | – | ﹤0.01% | 5247 |
|
|
2024
Q3 | $1.32K | Hold |
9,044
| – | – | ﹤0.01% | 5076 |
|
|
2024
Q2 | $800 | Hold |
9,044
| – | – | ﹤0.01% | 5160 |
|
|
2024
Q1 | $1.07K | Hold |
9,044
| – | – | ﹤0.01% | 5140 |
|
|
2023
Q4 | $2.5K | Hold |
9,044
| – | – | ﹤0.01% | 5157 |
|
|
2023
Q3 | $3.33K | Hold |
9,044
| – | – | ﹤0.01% | 5203 |
|
|
2023
Q2 | $5.17K | Hold |
9,044
| – | – | ﹤0.01% | 5222 |
|
|
2023
Q1 | $6.16K | Hold |
9,044
| – | – | ﹤0.01% | 5277 |
|
|
2022
Q4 | $6.47K | Hold |
9,044
| – | – | ﹤0.01% | 5417 |
|
|
2022
Q3 | $8K | Hold |
9,044
| – | – | ﹤0.01% | 5514 |
|
|
2022
Q2 | $8K | Buy |
+9,044
| New | +$8K | ﹤0.01% | 5553 |
|